Newsletter
Every new paper in this field, in your inbox.
Researchers present a groundbreaking laparoscopic liver tunnel technique for tumors at the hepatocaval confluence, expanding parenchyma-sparing surgery possibilities. A case study involving synchronous colorectal liver metastases demonstrates the feasibility of this approach, allowing resection of ill-located tumors with complex vascular relationships through minimally invasive means.…
Addressing the aggressive nature of pancreatic adenocarcinoma, this study outlines ASO practice guidelines for surgical and multimodal management. Focusing on resectable, borderline resectable, and locally advanced cases, the guidelines aim to equip surgical oncologists with current recommendations. By delving into the supporting data, the study…
Examining pancreatic ductal adenocarcinoma (PDAC) cases (1991-2020) with neoadjuvant treatment (NAT), this study categorizes fibrotic responses and explores their links to different NAT strategies (chemotherapy, chemoradiation, or total neoadjuvant therapy, TNT). Major fibrosis, most prevalent in TNT cases, correlates with superior outcomes, including higher rates…
In the clash of surgical titans for pancreatic or periampullary tumors, laparoscopic and open approaches square off. The 3-year showdown reveals no knockout punches. Among the contenders, laparoscopic pancreaticoduodenectomy (LPD) doesn't outshine open PD in the ring of overall survival (OS). Both LPD and open…
Surgeons pioneering laparoscopic spleen-preserving distal pancreatectomy (lspdp) embraced the gastrohepatic ligament approach, deftly navigating preservation of splenic vessels. With a concise operation time of 186 minutes and minimal blood loss (37 ml), their approach, showcased in a video, emerges as a strategic option for low-grade…
In the realm of pancreatoduodenectomy, a study unfolds a CT-based crystal ball. Researchers spot predictive markers—pancreatic neck thickness (>1.3 cm), intra-abdominal distance (>5.8 cm), soft pancreas, and narrow duct—signaling heightened risk of postoperative pancreatic fistula. Notably, abdominal wall thickness and obesity play no role. This…
For those tackling nonfunctioning pancreatic neuroendocrine neoplasms (NFPanNENs), the question was: How much lymph node removal is the sweet spot? This study dug into 84 patients' data, revealing that lymph node metastasis near the tumor was the key player in predicting a tough road ahead.…
In the robotic frontier of pancreaticoduodenectomy, a study of 400 patients revealed a 10.5% unplanned conversion rate. Men, especially, faced this detour, often due to vascular surprises or bleeding challenges. While conversions meant shorter surgeries, they spiked blood loss and complications, with higher mortality rates.…
Researchers delved into the impact of inpatient palliative care consultation (PCC) for pancreatic cancer, revealing a game-changer. Among 175,805 patients, PCC correlated with decreased costs, shorter cumulative hospital stays, and reduced 30-day readmissions. Despite a slight uptick in PCC utilization from 2016 to 2020, the…
In the liver cancer maze, SAGES/AHPBA experts wielded microwaves and radiofrequency ablation (RFA) to guide decisions for tumors under 5 cm. Assessing outcomes and techniques, they found evidence somewhat shaky but suggested both microwave (MWA) and RFA are viable for selected patients, with laparoscopic MWA…
